A detailed history of American Century Companies Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, American Century Companies Inc holds 32,802 shares of RPTX stock, worth $44,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,802
Previous 32,660 0.43%
Holding current value
$44,282
Previous $107,000 4.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.75 - $3.99 $390 - $566
142 Added 0.43%
32,802 $112,000
Q2 2024

Aug 07, 2024

BUY
$3.02 - $4.7 $670 - $1,043
222 Added 0.68%
32,660 $107,000
Q1 2024

May 14, 2024

BUY
$4.53 - $8.41 $27,664 - $51,359
6,107 Added 23.19%
32,438 $152,000
Q4 2023

Feb 13, 2024

BUY
$3.22 - $11.79 $84,785 - $310,442
26,331 New
26,331 $192,000
Q3 2023

Nov 13, 2023

BUY
$8.16 - $13.01 $42,219 - $67,313
5,174 Added 40.64%
17,904 $216,000
Q2 2023

Aug 14, 2023

BUY
$8.63 - $12.53 $109,859 - $159,506
12,730 New
12,730 $134,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.